Strengthening the National Sickle Cell Elimination Mission through universal access to point-of-care screening test
PLOS One · 13.08.2026 · 21 (8) · e0355845
DOI: 10.1371/journal.pone.0355845 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.08.2026. Verfasst von Beena Joshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operational and Implementation Research, Regional Resource Hub for Health Technology Assessment, ICMR National Institute for Research o…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Point-of-Care Testing, Mass Screening, Point-of-Care Systems. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The study aims to identify the most affordable point-of-care tests and their financial implications for the implementation of the universal screening of sickle cell disease in India.
Method
This study is a rapid health technology assessment from Indian public health system’s perspective using decision tree model for a hypothetical tribal population cohort of 0–40 years in six endemic states. Point-of-care (POC) tests (Hemotype Sc, Sickle Scan, Sickle CERT and Gazelle) were compared with the existing standard of care (SOC) – solubility test with confirmation using high-performance liquid chromatography, for universal screening and early detection of sickle cell disease/traits. The health system cost per case screened and detected were estimated along with budget impact for implementing the screening programs.
Results
The health system cost were higher for all the evaluated POC tests than SOC. The POC screening cost ranged from US$2.38 – US$3.85 per case and US$146.17 – US$230.73 per case detected, compared with US$0.67 and US$42.53 for SOC. However, POC test detected substantially more sickle cell disease cases, incrementally detecting 21,125−41,458 cases. Based on these findings, the National Health Mission directed states to publicly procure POC tests. The price negotiation resulting from the public tendering and competitive bidding resulted in-house manufacturing and validation of these kits lowering their prices substantially which enabled states procuring these POC tests at less than US$ 1.21 per test, potentially yielding US$37.86 million in savings with full coverage.
Conclusion
The rapid HTA provided the state governments with evidence-based guidance to negotiate procurement prices for the POCs which facilitated efficient budget allocation to implement sickle cell screening strategy effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Operational and Implementation Research, Regional Resource Hub for Health Technology Assessment, ICMR National Institute for Research on Women's Health (ICMR-NIRWoH), Mumbai, Maharashtra, India.
- Department of Health Research, Health Technology Assessment in India, Ministry of Health and Family Welfare, New Delhi, India.
- Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Beena Joshi, Shankar Prinja
Zitieren
APA
Joshi, B., Rajsekar, K., Jyani, G., Tyagi, K., Sachin, O., Revathy, R., Varekar, T., & Prinja, S. (2026). Strengthening the National Sickle Cell Elimination Mission through universal access to point-of-care screening test. PLOS One, 21(8), e0355845. https://doi.org/10.1371/journal.pone.0355845
Vancouver
Joshi B, Rajsekar K, Jyani G, Tyagi K, Sachin O, Revathy R, et al. Strengthening the National Sickle Cell Elimination Mission through universal access to point-of-care screening test. PLOS One. 2026;21(8):e0355845. doi:10.1371/journal.pone.0355845
BibTeX
@article{Joshi2026,
author = {Joshi, Beena and Rajsekar, Kavitha and Jyani, Gaurav and Tyagi, Kirti and Sachin, Oshima and Revathy, R and Varekar, Tejal and Prinja, Shankar},
title = {Strengthening the National Sickle Cell Elimination Mission through universal access to point-of-care screening test},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355845},
doi = {10.1371/journal.pone.0355845}
}
EUVIMED